Formal Name of the Test:
Drug Monitoring, Panel 7 with Confirmation, Urine
Other Names Used:
Prescription Drug Monitoring, Pain Management
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes.
The initial screen of 6-Acetylmorphine, Alcohol Metabolites, Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone drug classes. Specimen validity consists of Creatinine, Oxidant, and pH testing.
If the screen of the drug class is positive, confirmation of the drug class will be performed.
The confirmation includes the following analytes within their associated drug class:
Alcohol Metabolites: Ethyl Glucuronide (ETG), Ethyl Sulfate (ETS)
Amphetamines: Amphetamine, Methamphetamine
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone
There is no need for any prior preparation.
Test Performed at:
Quest Diagnostics, Test Code 39429
Click here to go to Quest Diagnostics page for this test